SCHEMBL27286147

SCHEMBL27286147

CC(=O)c1cnn(Cc2ccccc2C(=O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.43
BRD4 O60885 4/20 0.43
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 3/20 0.40
PKM P14618 1/20 0.40
KLKB1 P03952 3/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TSHR P16473 1/20 0.40
KDR P35968 1/20 0.40
HSD17B10 Q99714 1/20 0.40
FOLH1 Q04609 1/20 0.40
CREBBP Q92793 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27286149 0.85 LMNA (0.48) POLBALDH1A1LMNAHPGDKDM4E
SCHEMBL19087045 0.83 ALDH1A1 (0.44) L3MBTL1BRD4POLBTDP1ALDH1A1
SCHEMBL27286278 0.82 LMNA (0.37) L3MBTL1ALDH1A1LMNAHPGDMAPT
SCHEMBL27286140 0.82 ALDH1A1 (0.62) L3MBTL1ALDH1A1LMNAHPGDMAPT
SCHEMBL13692389 0.81 L3MBTL1 (0.54) L3MBTL1POLBTDP1ALDH1A1LMNA
SCHEMBL19077853 0.81 ALDH1A1 (0.41) L3MBTL1BRD4POLBTDP1ALDH1A1
SCHEMBL19116685 0.81 NR4A3 (0.43) L3MBTL1BRD4POLBTDP1ALDH1A1
SCHEMBL27376022 0.80 L3MBTL1 (0.47) L3MBTL1POLBALDH1A1LMNAHPGD
SCHEMBL27395876 0.80 ALDH1A1 (0.40) L3MBTL1BRD4POLBTDP1ALDH1A1
SCHEMBL27286277 0.79 AKR1C3 (0.40) L3MBTL1ALDH1A1HPGDKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026486-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed
WO-2024026483-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed
WO-2024026484-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed
WO-2024026481-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed